Lineage Cell Therapeutics
LCTX
#7616
Rank
A$0.57 B
Marketcap
A$2.29
Share price
-0.61%
Change (1 day)
265.21%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2025 (TTM): -A$31.88 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are A$10.81 Million. In 2024 the company made an earning of -A$30.01 Million, an increase over its 2023 earnings that were of -A$34.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$31.88 Million6.23%
2024 -A$30.01 Million-13.16%
2023 -A$34.56 Million9.83%
2022 -A$31.47 Million-54.24%
2021 -A$68.75 Million86.07%
2020 -A$36.95 Million-31.97%
2019 -A$54.31 Million-5.42%
2018 -A$57.43 Million1.1%
2017 -A$56.8 Million-31.06%
2016 -A$82.38 Million-10.38%
2015 -A$91.93 Million29.69%
2014 -A$70.89 Million31.68%
2013 -A$53.84 Million
2011 -A$26.13 Million89.78%
2010 -A$13.77 Million206.06%
2009 -A$4.5 Million-0.58%
2008 -A$4.53 Million164.89%
2007 -A$1.71 Million-30.22%
2006 -A$2.45 Million
2002 -A$2.85 Million-41.04%
2001 -A$4.83 Million-32.04%
2000 -A$7.1 Million-11.85%
1999 -A$8.05 Million
1997 -A$5.17 Million12.12%
1996 -A$4.62 Million106.25%
1995 -A$2.24 Million-11.11%
1994 -A$2.52 Million50%
1993 -A$1.68 Million20%
1992 -A$1.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.21 Billion 627.71%๐Ÿ‡บ๐Ÿ‡ธ USA